Investing.com - Collplant ADR reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Collplant ADR announced earnings per share of $-0.40 on revenue of $109K. Analysts polled by Investing.com anticipated EPS of $-0.31 on revenue of $3.1M.
Collplant ADR shares are down 68.15% from the beginning of the year and are trading at $5.21 , down-from-52-week-high.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings beat by AstraZeneca ADR on Thursday, November 10, 2022, who reported EPS of $1.67 on revenue of $10.98B, compared to forecasts EPS of $0.77 on revenue of $10.78B.
Amgen had beat expectations on Thursday, November 3, 2022 with third quarter EPS of $4.7 on revenue of $6.7B, compared to forecast for EPS of $4.44 on revenue of $6,561M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar